XClose

UCL Research Domains

Home
Menu

Partners

We greatly value our partnerships which allow us to push the boundaries and maximise the impact of new advances.

UCL is one of the five founding universities of the Alan Turing Institute. It is now the national institute for data science and artificial intelligence. UCL's relationship with the Alan Turing Institute provides opportunities for collaboration for academics, researchers and students.  Find out how to get involved.


ELLIS(European Laboratory for Learning and Intelligent Systems) is a European AI network of excellence comprising Units within 30 Universities. It focuses on fundamental science, technical innovation and societal impact. 

The ELLIS Unit at UCL spans multiple departments (Gatsby Computational Neuroscience Unit, Department of Computer Science, Department of Statistics) and includes 29 faculty across the three departments. Find out more.


INRIA logo, London skyline, and UCL Logo

A joint venture between UCL and Inria, one of the leading French research institutes in computer science and applied mathematics. Inria have launched ‘The Inria London Programme’, an initiative to establish a presence in the UK and serve as a hub to increase collaborations with UK partners, such as universities, research institutes and the private sector. UCL has initiated this venture as a founding strategic partner. Further details.


Health Data Research UK is the national institute for health data science. Professor Harry Hemingway, Director of the UCL Institite of Health Informatics, is the Director of HDR UK London, which brings together five London universities in partnerships for data science for health.  Find out more.


The Science and Engineering South (SES) Consortium brings together the universities of Oxford, Cambridge, Southampton, King’s College London, Queen Mary University of London, University College London and Imperial College London, creating the most powerful hub of research-intensive universities in the UK. SES supports and furthers research data and high performance computing.


The Met Office Academic Partnership (MOAP) brings together the Met Office and leading UK Universities in weather and climate science through a formal collaboration to advance the science and skill of weather and climate prediction. UCL’s contribution will be led by Joint Chair, Professor Serge Guillas (UCL Statistical Science). It involves researchers from three faculties and eight departments.

Through the partnership, UCL will build on existing Met Office collaborative projects to energise and modernise data science in weather and climate modelling to help tackle global issues. This includes sharing expertise in computer simulations, spatial data, trends and extremes, as well as research on space weather, including the development of techniques and data analysis for model validation, weather forecasting and climate projections. 


 

Francis Crick Institute Logo
The Francis Crick Institute is an inter-disciplinary medical research institute next to St Pancras railway station near UCL's Bloomsbury campus. Its work will help understand why disease develops and find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease and stroke, infections, and neurodegenerative diseases. It is a consortium of six of the UK's most successful scientific and academic organisations - the Medical Research Council, Cancer Research UK, the Wellcome Trust, UCL, Imperial College London and King's College London. 

 


Institute of Structural and Molecular Biology (ISMB) was founded in 2003 to promote multi-disciplinary research at the interface of structural-, computational- and chemical biology at UCL and Birkbeck.  It consists of the Department of Biological Sciences at Birkbeck, the Research Department of Structural & Molecular Biology at UCL, and the Chemical Biology section of the Department of Chemistry at UCL.. The ISMB has become one of the internationally premier institutions in multidisciplinary life sciences. Scientists at UCL and Birkbeck work hand-in-hand to deliver our mission, to push the frontiers of science and to communicate our discoveries in research-led teaching. Our research portfolio encompasses several foci, including (i) gene expression & RNA biology, (ii) protein folding, membranes & trafficking, (iii) microbiology & synthetic biology, (iv) metabolism, cancer & biological chemistry and (v) evolution, AI & deep learning.


Programming Historian logo
UCL Digital Humanities has joined the Programming Historian's Institutional Partnership Programme. For the past decade, Programming Historian has been an integral part of the digital humanities teaching and learning infrastructure, with more than 140 open access peer-reviewed tutorials published in 4 languages. With many universities around the world still not offering adequate digital skills training to their staff or students, projects such as this one remain crucial.

NIHR BRC logos

The UCLH Biomedical Research Centre (BRC) is a partnership between University College London Hospitals NHS Foundation Trust (UCLH) and UCL (University College London). By working together we have become leaders in translating fundamental biomedical research into clinical research that benefits patients. NIHR BRC status has enabled this successful partnership to build on our expertise in areas such as cancer, cardiovascular disease and neurosciences.

The NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. Our Biomedical Research Centre is dedicated to vision research.

The NIHR Great Ormond Street Hospital Biomedical Research Centre (BRC) supports medical research for children and young people at Great Ormond Street Hospital (GOSH) and the UCL Institute of Child Health (ICH). The funding enables basic scientific discoveries made in laboratories to be translated into ‘first in man’ or ‘first in child’ clinical studies. Our research aims to accelerate discoveries into the basis of childhood rare diseases and to develop new diagnostics, imaging techniques and treatments, including cellular and gene therapies.